Does Drugs That Prolong Qtc Interval Interact with Cabotegravir And Rilpivirine?
Drugs That Prolong Qtc Interval and Cabotegravir And Rilpivirine have a moderate drug interaction according to U.S. FDA drug labeling data. CABENUVA should be used with caution in combination with drugs with a known risk of Torsade de Pointes due to rilpivirine's potential to prolong QTc interval at elevated concentrations. The mechanism involves additive qt prolongation risk. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Drugs That Prolong Qtc Interval and Cabotegravir And Rilpivirine occurs because additive qt prolongation risk. Clinically, this means cabenuva should be used with caution in combination with drugs with a known risk of torsade de pointes due to rilpivirine's potential to prolong qtc interval at elevated concentrations. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Drugs That Prolong Qtc Interval and your doctor is considering prescribing Cabotegravir And Rilpivirine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider